Today’s top gainers include the company Medivation, Inc. (NASDAQ:MDVN) which is in the industry Biotechnology, gaining 0.68% today. In the last week its performance is 0.39%, and 20.30% for the past quarter. Currently, Medivation, Inc., MDVN has a target price of 64.65, so today’s gain of 0.68% is a significant step towards its target price. The GAP today is therefore 0.52%.
Medivation, Inc. (NASDAQ:MDVN), has a market cap of 10152.29, and is based in USA. Insider ownership is at 1.20%, and institutional ownership is 92.80%.
At the current price of 62.23, it has a dividend yield of *TBA, and its target price is 64.65. This is with a profit margin of 25.40%, and total debt/equity of 0. Medivation, Inc. (NASDAQ:MDVN) has a P/E of 43.22, as well as a forward P/E of 27.73.
With a current EPS of 1.43, and a forecasted EPS growth for next year at 72.52%,Medivation, Inc. (NASDAQ:MDVN) has had a EPS growth for the past five years at 50.90%. For the next five years EPS growth is projected to be 35.15%.
Performance for the year is 12.75%. Since its IPO date on 1/13/1997, the total performance to date is 27.87%.
Volume today for Medivation, Inc. (NASDAQ:MDVN), is 2343661, while its average volume is 2768.31. Whilst the total gain today was 0.68%, it did have a day high of -1.19%.
Volatility for this week has been at 0.93%, and 1.89% for the month. The 52-week low for Medivation, Inc., MDVN has been 135.63%, while the 52-week-high has reached -1.19%.
Looking at its return of investments, which is 27.10%, and its return on assets is 21.50%. Medivation, Inc. (NASDAQ:MDVN) has an operating margin of 40.20%. With a sales growth of 41.30% quarter over quarter. Bearing in mind that Medivation, Inc., MDVN is in the sector Healthcare, its long-term debt/equity is 0, and has a current ratio of 4.2 and 4.2 for quick ratio.
So what is the value of Medivation, Inc.? Well its PEG is 1.23, and the P/S is 10.19, along with a P/B of 11.28. Meanwhile it has a p/cash of *TBA.